BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K, Toyoshima A, Nagata K, Haberkorn U, Kratochwil C, Shinohara A, Hatazawa J, Giesel F. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. Eur J Nucl Med Mol Imaging 2021. [PMID: 34537893 DOI: 10.1007/s00259-021-05554-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Hua Y, Shen Q, Yu C. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer. Nucl Med Commun 2022. [PMID: 35506275 DOI: 10.1097/MNM.0000000000001565] [Reference Citation Analysis]
2 Coria-domínguez L, Vallejo-armenta P, Luna-gutiérrez M, Ocampo-garcía B, Gibbens-bandala B, García-pérez F, Ramírez-nava G, Santos-cuevas C, Ferro-flores G. [99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients. Pharmaceuticals 2022;15:590. [DOI: 10.3390/ph15050590] [Reference Citation Analysis]
3 Yoshimoto M, Yoshii Y, Matsumoto H, Shinada M, Takahashi M, Igarashi C, Hihara F, Tachibana T, Doi A, Higashi T, Fujii H, Washiyama K. Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy. Pharmaceutics 2021;13:1706. [PMID: 34683999 DOI: 10.3390/pharmaceutics13101706] [Reference Citation Analysis]
4 van Dam MA, Vuijk FA, Stibbe JA, Houvast RD, Luelmo SAC, Crobach S, Shahbazi Feshtali S, de Geus-Oei LF, Bonsing BA, Sier CFM, Kuppen PJK, Swijnenburg RJ, Windhorst AD, Burggraaf J, Vahrmeijer AL, Mieog JSD. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers (Basel) 2021;13:6088. [PMID: 34885196 DOI: 10.3390/cancers13236088] [Reference Citation Analysis]
5 Hatazawa J. The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update. Semin Nucl Med 2022:S0001-2998(22)00019-8. [PMID: 35346487 DOI: 10.1053/j.semnuclmed.2022.02.005] [Reference Citation Analysis]
6 Wen X, Xu P, Shi M, Liu J, Zeng X, Zhang Y, Shi C, Li J, Guo Z, Zhang X, Khong PL, Chen X. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics. Theranostics 2022;12:422-33. [PMID: 34987657 DOI: 10.7150/thno.68182] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]